Skip to Main Content

Paper Details

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.
Cell
166
2021
ACE2, COVID-19, CoV, N, NTD, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 spike protein, anti-spike monoclonal antibodies, coronavirus disease 2019, infectivity, infectivity-enhancing site, patients
Author NameAffiliation
Daron M StandleyResearch Institute for Microbial Diseases, Osaka University, Japan Center for Infectious Disease Education and Research
Daron M StandleyResearch Institute for Microbial Diseases, Osaka University, Japan Center for Infectious Disease Education and Research
  • 1 - 2

Datasets

Release 1.2